OPRX · Nasdaq
Companies at this level ended the following year delisted, bankrupt, restated or silent 9.2% of the time, against 4.0% for companies with a clean record.
Hover or tap a dot to see the filings behind that score.
OptimizeRx Corporation (the “Company”) was unable to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the “Form 10-Q”) within the prescribed date and time deadline of 5:30 p.m. (EDT), August 14, 2024, without unreasonable effort or expense, as a result of the Company not providing its financial printer with sufficient time required to prepare the XBRL for the filing of the Form 10-Q. The Company has submitted its Form 10-Q to its financial printer for preparing the XBRL and is awaiting filing. The Company expects to file its Form 10-Q prior to the end of the fifth calendar day extension period provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended. 2
NT 10-Q, filed 2024-08-15 · XBRL or exhibits
2026-03-30auditor changed or resigned SEC →
OptimizeRx Corporation (the “Company”) was unable to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2024 (the “Form 10-Q”) within the prescribed date and time deadline of 5:30 p.m. (EDT), August 14, 2024, without unreasonable effort or expense, as a result of the Company not providing its financial printer with sufficient time required to prepare the XBRL for the filing of the Form 10-Q. The Company has submitted its Form 10-Q to its financial printer for preparing the XBRL and is awaiting filing. The Company expects to file its Form 10-Q prior to the end of the fifth calendar day extension period provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended. 2
OptimizeRx Corporation (the “Company”) is unable to file its Annual Report on Form 10-K for the year ended December 31, 2023 (the “2023 Annual Report”) within the prescribed time period without unreasonable effort or expense because of the circumstances described below. The Company experienced delays in (i) compiling and finalizing accounting documentation associated with its October 2023 acquisition of Healthy Offers, Inc. (dba Medicx Health) and the November 2023 operational realignment to focus on core business lines, and (ii) performing further remediation of the previously disclosed material weakness related to the testing and validation of internal processes tied to certain third-party vendors more fully described in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. The Company expects to file its Form 10-K prior to the end of the fifteenth calendar day extension period provided by Rule 12b-25 of the Securities Exchange Act of 1934, as amended
reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.
Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.
See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.Every item above is a filing this company
made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not
investment advice